Диссертация (Нарушение функции подоцитов и механизмов самозащиты почки - значение в оценке активности и прогноза хронического гломерулонефрита), страница 31

- р.423-433.261.Romagnani P, Lasagni L, Remuzzi G. Renal progenitors: An evolutionaryconserved strategy for kidney regeneration// Nat Rev Nephrol. – 2013. - №9. –р.137–46.262.Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P. et al.Role of IL-6 and its soluble receptor in induction of chemokines and leukocyterecruitment// Immunity.

– 1997. - №6. – р.315–25.263.Ronco P, Chatziantoniou C. Matrix metalloproteinases and matrix receptorsin progression and reversal of kidney disease: therapeutic perspectives// Kidney Int.- 2008. - №74. – р.873–878.264.RoncoP,LelongtB,PiedagnelR,ChatziantoniouC.Matrixmetalloproteinases in kidney disease progression and repair: a case of flipping thecoin// Semin Nephrol. – 2007. - №27. – р.352–362.265.Sadeghi M, Daniel V, Naujokat C, Weimer R, Opelz G. Strikigly higherinterleukin (IL)-1, IL-1 and soluble interleukin-1 receptor antagonist (sIL-1ra)but similar IL-2, sIL-2r, IL-3, IL-4, IL-6, sIL-6r, IL-10, tumor necrosis factor(TNF)-, transforming growth factor (TGF)-2 and interferon IFN- urine levels inhealthy females compared to healthy males: protection against urinary tract injury?//Clin Exp Immunol.

– 2005. - №142. – р. 312-317.266.Samson J.N. Regulation of antigen-specific regulatory T-cell induction vianasal and oral mucosa// Crit Rev Immunol. – 2004. - №24. – р. 157-177.267.Sanchez-NinoMD,SanzAB,Sanchez-LopezE,Ruiz-OrtegaM,AlbertoBenito-Martin A, Saleem MA, Mathieson PW, Mezzano S, Egido J, Ortiz A.HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by highglucose and angioten:in II// Laboratory Investigation.

– 2012. - №92. – р. 32–45.268.Saran AM, Yuan H, Takeuchi E, McLaughlin M, Salant DJ. Complement202mediates nephrin redistribution and actin dissociation in experimental membranousnephropathy// Kidney Int. – 2003. - №64. – р. 2072-2078.269.Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M. et al.Urine podocyte mRNAs mark progression of renal disease// J Am Soc Nephrol.

2009. - №20. – р. 1041–52.270.Scheffold A, Murphy KM, Hofer T. Competition for cytokines: T(reg) cellstake all// Nat Immunol. – 2007. - №8. – р. 1285-1287.271.Schiffer M, Bitzer M, Roberts IS. Apoptosis in podocytes induced by TGF-beta and Smad7// J Clin Invest. – 2001. - №108. – р.807–816.272.Schneider A, Panzer U, Zahner G. et al.

Monocyte chemoattractant protein-1mediates collagen deposition in experimental glomerulonephritis by transforminggrowth factor-beta// Kidney Int. – 1999. - №56(1). – р. 135-144.273.Schober A, Burger-Kentischer A, Muller E, Beck F-X. Effect of ischemia onlocalization of heat shock proteins in kidney// Kidney Int. – 1998. – 54. – р. 174176.274.Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelialgrowth factor (VEGF) in renal pathophysiology// Kidney International. – 2004. –65(6).

- p. 2003–2017.275.Sedor JR, Nakazato Y, Konieczkowski M. Interleukin-1 and the mesangialcell// Kidney Int. – 1992. - №41. – р. 595-599.276.Segerer S, Cui Y, Hudkins KL, Goodpaster T, Either F,SchlondorffD,AlpersCE.ExpressionoftheChemokineMack M,MonocyteChemoattractant Protein -1 and its Receptor Chemokine Receptor 2 in humancrescentic glomerulonephritis// J Am Soc Nephrol. – 2000.

- №11. – р.2231-2242.277.Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the targetfor aldosterone. Role of oxidative stress and Sgk1// Hypertension. – 2007. - № 49. –р. 355-364.278.Shirato I, Sakai T, Kimura K, Tomino Y, Kriz W. Cytoskeletal changes inpodocytes associated with foot process effacement in Masugi nephritis// Am J203Pathol. – 1996. – 148. – р.1283–1296.279.Shirato I. Podocyte process effacement in vivo// Micros Res Tech.

– 2002. -№57. – р. 241–246.280.Shulman K. et al. Expression of vascular permeability factor (VPF/VEGF) isaltered in many glomerulardisease // J Am Soc Nephrol. – 1996. - №7. –р. 661‐666.281.Simon M, Grone HJ, Johren O. et al. Expression of vascular endothelialgrowth factor and its receptors in human renal ontogenesis and in adult kidney//American Journal of Physiology. – 1995.

– 268 (2). - p. 240–250.282.Simon M, Rockl W, Hornig C. et al. Receptors of vascular endothelial growthfactor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney:localization and [125I]VEGF binding sites// Journal of the American Society ofNephrology. -1998. – 9(6).

– р. 1032–1044.283.Smith MF, Eidlen D, Arend WP, Gutierrez-Hartmann A. LPS-inducedexpression of the human IL-1 receptor antagonist gene is controlled by multipleinteracting promoter elements// J Immunol. – 1994. - №153. – р. 3584-3593.284.Smoyer WE, Gupta A, Mundel P, Ballew JD, Welsh MJ. Altered expressionof glomerular heat shock protein 27 in experimental nephrotic syndrome// J ClinInvest.

– 1996. – №97. – р. 2697-2704.285.Smoyer WE, Ranson RF. Hsp27 regulates podocyte cytoskeletal changes inan in vitro model of podocyte process retraction// FASEB J. – 2002. - №16. – р.316326.286.Srivastava T, Sharma M, Yew KH, Sharma R, Duncan RS, Saleem MA. et al.LPS and PAN-induced podocyte injury in an in vitro model of minimal changedisease: changes in TLR profile// J Cell Commun Signal. – 2013.

- №7. – р.49–60.287.Steinmann-Niggli K, Ziswiler R, Kung M, Marti HP. Inhibition of matrixmetalloproteinases attenuates anti-Thy1.1 nephritis// J Am Soc Nephrol. – 1998. №9. – р. 397–407.204288.Stenvinkel P, Ketteler M, Jonson JR, Lindholm B. et al. IL-10, Il-6 and TNF-: Central factors in the altered cytokine network of uremia – The good, the bad,and the ugly// Kidney Int. – 2005. - № 67. – р.

1216-1233.289.Stephan M, Conrad S, Eggert T. et al. Urinary concentration and tissuemessenger RNA expression of monocyte chemoattractant protein-1 as an indicatorof the degree of hydronephrotic atrophy in partial ureteral obstruction// J Urol. 2002. - №167. – р.1497-1502.290.Strassmann G, Patil-Koota V, Finkelman F, Fong M, Kambayashi T.Evidence for the involvement of interleukin 10 in the differential deactivation ofmurine peritoneal macrophages by prostaglandin E2// J Exp Med.

– 1994. – 180. –р. 2365-2370.291.Sturfelt G, Roux-LombardP, Wollheim FA, Dayer J-M. Low levels ofinterleukin-1 receptor antagonist coincide with kidney involvement in systemiclupus erythematosus// British J Rheumatology. – 1997.

- №36. – р.1283-1289.292.Suberville S, Bellocq A, Fouqueray B, Philippr C, Lantz O, Perez J, Baund L.Regulation of interleukin-10 production by -adrenergic agonists// Eur J Immunol. .– 1996. - №26. - р.2601-2605.293.Sugimoto H, Hamanog Y, Charytan D. et al. Neutralization of circulatingvascular endothelial growth factor (VEGF) by anti-VEGF antibodies and solubleVEGF receptor 1 (sFlt1) induces proteinuria// Journal of Biological Chemistry. –2003.

– 278 (15). - p. 12605–12608.294.Taal MW, Zandi-Nejad K, Weening B. et al. Proinflammatory geneexpression and macrophage recruitment in the rat remnant kudney// Kidney Int. –2000. – 58. – р.1664-1676.295.Taams LS, van Amelsfort JM, Tiemessen MM, Jacobs KM, de Jong EC,Akbar AN, Bijlsma JW, Lafeber FP. Modulation of monocyte/macrophage functionby human CD4+/CD25+ regulatory T cells// Hum Immunol.

– 200. - №66. – р. 222230.205296.Tam FM, Karkar AM, Smith J, Yoshimura T, Steinkasserer A, Kurrle R,Langner K, Rees AJ. Differential expression macrophage inflammatory protein-2and monocyte chemoattractant protein-1 in experimental glomerulonephritis//Kidney Int. – 1996. - №49. – р. 715-721.297.Tam FWK, Smith J, Cashman SJ, Wang Y, Thompson EM, Rees AJ.Glomerular expression of interleukin receptor antagonist and interleukin-1 genesin antibody-mediated glomerulonephritis// Am J Pathol.

– 1994. - №145. – р. 126136.298.Tan TK, Zheng G, Hsu TT, Wang Y, Lee VW, Tian X, Wang Y, Cao Q,Wang Y, Harris DC. Macrophage matrix metalloproteinase-9 mediates epithelialmesenchymal transition in vitro in murine renal tubular cells// Am J Pathol. – 2010.- №176.- р. 1256–1270.299.Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G, Gambino R,Vergola D, Pinach S, Perin PC, Camussi G, Gruden G. Effect of the monocytechemoattractant protein-1/CC chemokine receptor 2 system on nephrin expressionin streptozotocin-treated mice and human cultured podocytes// Diabetes. – 2009.

58(9). – р. 2109-18.300.Tesh GN, Lan HY, Atkins RC, Nikolic-Paterson DJ. Role of interleukin-1 inmesangial proliferation and matrix deposition in experimental mesangioproliferativenephritis// Am J Pathol. – 1997. - №151. – р.141-150.301.Tipping PG, Kitching AR, Huang XR, Mutch DA, Holdsworth SR.

Immunemodulation with interleukin-4 and interleukin-10 prevent crescent formation andglomerular injury in experimental glomerulonephritis// Eur J Immunol. - 1997. №27. – р.530-537.302.Topham PS, Haydar SA, Kuphal R. et al. Complement-mediated injuryreversibly disrupts glomerular epithelial cell actin microfilaments and focaladhesion// Kidney Int.

– 1999. - №55. – р. 1763-1775.303.Trieb К, Blahovec H, Margreiter R, Dirnhofer S, Krumböck N, FeichtingerH, Sgonc R. Heat shock protein expression in the transplanted human kidney//206Transplant International. – 2005. - №14(5). – р. 281-286.304.Trimarchi H. Podocyturia: what is in a name? //J Transl Int Med. – 2015. -№3(2). – р. 51-56.305.Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration:Nephrin a key component of the slit diaphragm// J Am Soc Nephrol. – 1999. - №10.– р. 2440-2445.306.Tryggvason K, Heikkila P, Pettersson E, Tibell A, Thorner P. Can Alportsyndrome be treated by gene therapy? //Kidney Int. – 1997. - №51.

– р.1493-1499.307.Tsagalis GC, Nikolopoulou N, Sotsiou F, Hadjiconstantinou V. Theexpression of heat shock proteins 27 and 70 in lupus nephritis// Hospital Chronicles.- 2006. - №1(3). – р.125-129.308.Tytell M, Greenberg SG, Lasek RJ. Heat shock-like protein is transferredfrom glia to axon// Brain Res. - 1986. - №363. – р.161–164.309.Urushihara M, Kagami S, Kuhara T, Tamaki T, Kuroda Y. Glomerulardistribution and gelatinolytic activity of matrix metalloproteinases in humanglomerulonephritis// Nephrol Dial Transplant. – 2002. - №17. – р.1189–1196.310.Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning KJ, HackerH, Wagner H.